Sight Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	81.06	71.33	48.96	27.64	23.35	7.53
Revenue Growth (YoY)	13.63%	45.70%	77.12%	18.38%	210.07%	-
Cost of Revenue	11.88	12.36	8.61	9.21	6.54	2.34
Gross Profit	69.18	58.97	40.35	18.43	16.8	5.19
Selling, General & Admin	108.89	120.07	76.19	41.75	32.72	14.06
Research & Development	17.56	22.86	15.63	8.87	8.12	5.43
Operating Expenses	126.45	142.92	91.82	50.62	40.84	19.49
Operating Income	-57.27	-83.95	-51.48	-32.19	-24.04	-14.3
Interest Expense / Income	5.41	4.47	4.37	2.4	1.96	0
Other Expense / Income	-7.25	-2.23	6.93	0.04	-0.14	-0
Pretax Income	-55.44	-86.2	-62.77	-34.63	-25.86	-14.3
Income Tax	0.11	0.05	0.19	0.06	0.01	-0.01
Net Income	-55.55	-86.24	-62.96	-34.69	-25.87	-14.29
Shares Outstanding (Basic)	49	48	27	9	9	9
Shares Outstanding (Diluted)	49	48	27	9	9	9
Shares Change	1.63%	78.98%	185.74%	-0.33%	1.78%	-
EPS (Basic)	-1.14	-1.80	-2.36	-3.71	-2.76	-1.55
EPS (Diluted)	-1.14	-1.80	-2.36	-3.71	-2.76	-1.55
Free Cash Flow	-47.98	-76.94	-53.35	-33.13	-25.67	-15.05
Free Cash Flow Per Share	-0.99	-1.61	-2.00	-3.54	-2.73	-1.63
Gross Margin	85.34%	82.67%	82.41%	66.68%	71.97%	68.95%
Operating Margin	-70.66%	-117.70%	-105.15%	-116.45%	-102.96%	-189.87%
Profit Margin	-68.53%	-120.90%	-128.61%	-125.52%	-110.80%	-189.77%
Free Cash Flow Margin	-59.19%	-107.86%	-108.98%	-119.85%	-109.94%	-199.80%
EBITDA	-48.41	-80.48	-57.21	-31.11	-23.47	-14.23
EBITDA Margin	-59.72%	-112.82%	-116.85%	-112.56%	-100.51%	-189.02%
Depreciation & Amortization	1.62	1.25	1.2	1.12	0.43	0.06
EBIT	-50.03	-81.73	-58.41	-32.23	-23.9	-14.3
EBIT Margin	-61.72%	-114.58%	-119.30%	-116.60%	-102.36%	-189.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).